{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:29:45Z","timestamp":1795026585015,"version":"4.10.2"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:p>High-grade neuroendocrine carcinomas (NEC) of the endometrium are rare and account for &lt;1% of all endometrial carcinomas. Both small cell neuroendocrine carcinoma (SCNEC) and large cell neuroendocrine carcinoma (LCNEC) morphologies have been reported. Little is known regarding the molecular features of endometrial NEC including how they compare to pulmonary NEC (the most common site for these neoplasms) and the more common endometrial carcinoma histotypes. In this study, we investigated the molecular alterations in a series of endometrial NEC using a targeted next generation sequencing panel (Oncopanel). Fourteen NEC were sequenced; pure NEC (n=4) and mixed (n=10) with endometrioid adenocarcinoma (n=9) or carcinosarcoma (n=1). The NEC components of mixed tumors comprised LCNEC (n=6) and SCNEC (n=4). The 4 pure NEC comprised LCNEC (n=2) and SCNEC (n=2). Molecular analysis classified tumors into the 4 The Cancer Genome Atlas groups: (1) <jats:italic toggle=\"yes\">POLE<\/jats:italic>-mutated\/ultramutated (1\/14; 7%), (2) microsatellite instability\/hypermutated (6\/14; 43%), (3) <jats:italic toggle=\"yes\">TP53<\/jats:italic> mutated\/copy number high (2\/14; 14%), or (4) no specific molecular profile (5\/14; 36%). Overall, 50% of cases were ultramutated or hypermutated. In 8 cases of mixed carcinomas, the different histologic components were macrodissected and separately sequenced; molecular alterations were nearly identical among the 2 components, with the non-NEC component harboring slightly increased tumor mutational burden. Only 2 carcinomas (both with pure SCNEC morphology) had a molecular profile that would be expected in typical pulmonary SCNEC (<jats:italic toggle=\"yes\">RB1<\/jats:italic> deletion and <jats:italic toggle=\"yes\">TP53<\/jats:italic> mutations). Our findings, similar to data from NECs of other anatomic sites, suggest that the molecular context may be important when selecting therapies for women with endometrial NEC. Immune checkpoint inhibition may be a reasonable approach to treatment of microsatellite instability-NEC and we thus recommend that all endometrial NEC be tested for mismatch repair abnormalities, either molecularly or by mismatch repair protein immunohistochemistry.<\/jats:p>","DOI":"10.1097\/pas.0000000000001560","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T07:48:02Z","timestamp":1596872882000},"page":"1541-1548","source":"Crossref","is-referenced-by-count":40,"title":["Molecular Characterization of Neuroendocrine Carcinomas of the Endometrium"],"prefix":"10.1097","volume":"44","author":[{"given":"Brooke E.","family":"Howitt","sequence":"first","affiliation":[{"name":"Women\u2019s and Perinatal Pathology Division"},{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Vivero","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Pathology, Royal Gwent Hospital, Wales"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Lindeman","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Kenneth","family":"Schoolmeester","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Baltay","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"MacConaill","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette M.","family":"Sholl","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa R.","family":"Nucci","sequence":"additional","affiliation":[{"name":"Women\u2019s and Perinatal Pathology Division"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Glenn","family":"McCluggage","sequence":"additional","affiliation":[{"name":"Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,8,7]]},"reference":[{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s13691-016-0263-9","article-title":"Combined large cell neuroendocrine carcinoma and endometrioid carcinoma of the endometrium: a shared gene mutation signature between the two histological components","volume":"6","author":"Ariura","year":"2017","journal-title":"Int Cancer Conf J"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.amsu.2015.12.055","article-title":"Small cell neuroendocrine carcinoma of the endometrium with pulmonary metastasis: a clinicopathologic study of a case and a brief review of the literature","volume":"5","author":"D\u2019Antonio","year":"2016","journal-title":"Ann Med Surg"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.prp.2016.03.009","article-title":"Metastatic large cell neuroendocrine carcinoma of the lung arising from the uterus: a pitfall in lung cancer diagnosis","volume":"212","author":"Ono","year":"2016","journal-title":"Pathol Res Pract"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/jog.12881","article-title":"Combined large-cell neuroendocrine carcinoma and endometrioid adenocarcinoma of the endometrium: a case report and survey of related literature","volume":"42","author":"Matsumoto","year":"2016","journal-title":"J Obstet Gynaecol Res"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/pgp.0b013e31806219c5","article-title":"Combined large cell neuroendocrine and endometrioid carcinoma of the endometrium","volume":"27","author":"Mulvany","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.bulcan.2018.06.007","article-title":"Small cell carcinoma of the endometrium: a clinicopathological study and management of three cases","volume":"105","author":"Sidibe","year":"2018","journal-title":"Bull Cancer"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.gore.2016.07.004","article-title":"Serous carcinoma of endometrium in combination with neuroendocrine small-cell: a case report and literature review","volume":"17","author":"Brudie","year":"2016","journal-title":"Gynecol Oncol Rep"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.prp.2009.12.008","article-title":"Large cell neuroendocrine carcinoma with sarcomatous changes of the endometrium: a case report with immunohistochemical studies and molecular genetic study of KIT and PDGFRA","volume":"206","author":"Terada","year":"2010","journal-title":"Pathol Res Pract"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.5858\/132.11.1821","article-title":"Combined large cell neuroendocrine carcinoma and papillary serous carcinoma of the endometrium with pagetoid spread","volume":"132","author":"Posligua","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"e16433","DOI":"10.1097\/MD.0000000000016433","article-title":"Mixed large and small cell neuroendocrine carcinoma of the endometrium with serous carcinoma: a case report and literature review","volume":"98","author":"Hu","year":"2019","journal-title":"Medicine"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/PAS.0000000000000633","article-title":"Neuroendocrine carcinoma of the endometrium: a clinicopathologic study of 25 cases","volume":"40","author":"Pocrnich","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.3802\/jgo.2019.30.e103","article-title":"Clinicopathologic features, treatment, prognosis and prognostic factors of neuroendocrine carcinoma of the endometrium: a retrospective analysis of 42 cases from the Kansai Clinical Oncology Group\/Intergroup study in Japan","volume":"30","author":"Matsumoto","year":"2019","journal-title":"J Gynecol Oncol"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.pathol.2019.02.003","article-title":"Expression of neuroendocrine markers in non-neuroendocrine endometrial carcinomas","volume":"51","author":"Moritz","year":"2019","journal-title":"Pathology"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5858\/arpa.2016-0527-OA","article-title":"Validation of OncoPanel: a targeted next-generation sequencing assay for the detection of somatic variants in cancer","volume":"141","author":"Garcia","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"e87062","DOI":"10.1172\/jci.insight.87062","article-title":"Institutional implementation of clinical tumor profiling on an unselected cancer population","volume":"1","author":"Sholl","year":"2016","journal-title":"JCI Insight"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41379-018-0125-4","article-title":"Targeted next-generation sequencing in the detection of mismatch repair deficiency in endometrial cancers","volume":"32","author":"Dong","year":"2019","journal-title":"Mod Pathol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/IGC.0000000000000888","article-title":"CD56 (neural cell adhesion molecule) expression in ovarian carcinomas: association with high-grade and advanced stage but not with neuroendocrine differentiation","volume":"27","author":"Bosmuller","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1365-2559.2010.03486.x","article-title":"Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability","volume":"56","author":"Den Bakker","year":"2010","journal-title":"Histopathology"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0046-8177(98)90047-8","article-title":"Reproducibility of neuroendocrine lung tumor classification","volume":"29","author":"Travis","year":"1998","journal-title":"Hum Pathol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/PGP.0b013e3181895539","article-title":"The significance of neuroendocrine expression in undifferentiated carcinoma of the endometrium","volume":"28","author":"Taraif","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40425-017-0281-y","article-title":"Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden","volume":"5","author":"Wang","year":"2017","journal-title":"J Immunother Cancer"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.humpath.2017.11.006","article-title":"Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study","volume":"72","author":"Espinosa","year":"2018","journal-title":"Hum Pathol"},{"issue":"suppl 1","key":"R25-20230922","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/PGP.0000000000000491","article-title":"High-grade endometrial carcinomas: morphologic and immunohistochemical features, diagnostic challenges and recommendations","volume":"38","author":"Murali","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ctrv.2017.04.002","article-title":"Unraveling molecular pathways of poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: a systematic review","volume":"56","author":"Girardi","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1530\/ERC-14-0410","article-title":"Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity","volume":"22","author":"Sahnane","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/modpathol.2016.220","article-title":"Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas","volume":"30","author":"Jesinghaus","year":"2017","journal-title":"Mod Pathol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.humpath.2015.11.004","article-title":"Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival","volume":"49","author":"Olevian","year":"2016","journal-title":"Hum Pathol"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/his.13875","article-title":"Colorectal large-cell neuroendocrine carcinoma with lymphoid stroma: further evidence confirming a unique subtype associated with MLH1\/PMS2 loss, BRAF mutation, Epstein-Barr virus negativity, and the possibility of a better prognosis","volume":"75","author":"Chetty","year":"2019","journal-title":"Histopathology"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1158\/1078-0432.CCR-15-2946","article-title":"Next-generation sequencing of pulmonary large cell neuroendocrine carcinoma reveals small cell carcinoma-like and non-small cell carcinoma-like subsets","volume":"22","author":"Rekhtman","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/modpathol.2017.110","article-title":"Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations","volume":"31","author":"Rekhtman","year":"2018","journal-title":"Mod Pathol"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1158\/1078-0432.CCR-17-1921","article-title":"Molecular subtypes of pulmonary large-cell neuroendocrine carcinoma predict chemotherapy treatment outcome","volume":"24","author":"Derks","year":"2018","journal-title":"Clin Cancer Res"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1634\/theoncologist.2016-0517","article-title":"Exceptional response to nivolumab and stereotactic body radiation therapy (SBRT) in neuroendocrine cervical carcinoma with high tumor mutational burden: management considerations from the center for personalized cancer therapy at UC San Diego Moores Cancer Center","volume":"22","author":"Sharabi","year":"2017","journal-title":"Oncologist"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001560","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:55:53Z","timestamp":1695423353000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001560"}},"subtitle":["Representation in All 4 TCGA Groups"],"short-title":[],"issued":{"date-parts":[[2020,8,7]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001560","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,7]]}}}